Elixinol confirms new CEO and shift away from CBD
Cannabis Law Report
AUGUST 1, 2022
expected from US Covid-19 relief measures. The company reported Q2 FY22 revenue of A$1.7m, up 13% on the previous quarter, while operating cash used was down 36% to $2.1m. It finished the quarter with $8.5m in funds, including $6.9m in cash and an additional $1.6m
Let's personalize your content